Condition
Mendelian Susceptibility to Mycobacterial Disease
Total Trials
2
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Enrolling By Invitation1
Recruiting1
Clinical Trials (2)
Showing 2 of 2 trials
NCT07284641Phase 2Recruiting
Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)
NCT01852370Phase 1Enrolling By Invitation
Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases
Showing all 2 trials